Eurofins acquires VIBT

12-May-2014 - Germany

Eurofins Scientific has signed a definitive agreement to acquire ViraCor-IBT Laboratories, Inc. from majority owner Ampersand Capital and other shareholders for approximately $255m, subject to post-closing adjustments.

Comment from Dr. Gilles Martin, Eurofins CEO: “This acquisition reflects our strategy of expanding our network of competence centers. VIBT provides Eurofins strong entry and leadership position in the specialty diagnostic testing market, thereby significantly enhancing our capabilities in pharmaceutical testing. Furthermore, the addition of VIBT into the Eurofins Group allows Eurofins to leverage its renowned competence in genomic testing to better serve the global healthcare community.”

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy